Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Immune Globulins market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period.
This report presents the market size and development trends by detailing the Immune Globulins market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Immune Globulins market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Immune Globulins industry and will help you to build a panoramic view of the industrial development.
Immune Globulins Market, By Type:
IVIg Liquid
IVIg Powder
Immune Globulins Market, By Application:
Immunodeficiency
Autoimmune Disease
Acute Infection
Some of the leading players are as follows:
CSL
BPL
Kedrion
Grifols
Sichuan Yuanda Shuyang
CNBG
Biotest
Octapharma
CBPO
Hualan Bio
Baxter
LFB Group
Shanghai RAAS
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Immune Globulins Market: Technology Type Analysis
-
4.1 Immune Globulins Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Immune Globulins Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 IVIg Liquid
4.3.2 IVIg Powder
5 Immune Globulins Market: Product Analysis
-
5.1 Immune Globulins Product Market Share Analysis, 2018 & 2026
-
5.2 Immune Globulins Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Immune Globulins Market: Application Analysis
-
6.1 Immune Globulins Application Market Share Analysis, 2018 & 2026
-
6.2 Immune Globulins Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Immunodeficiency
6.3.2 Autoimmune Disease
6.3.3 Acute Infection
7 Immune Globulins Market: Regional Analysis
-
7.1 Immune Globulins Regional Market Share Analysis, 2018 & 2026
-
7.2 Immune Globulins Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 CSL
9.1.1 CSL Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 BPL
9.2.1 BPL Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Kedrion
9.3.1 Kedrion Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Grifols
9.4.1 Grifols Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sichuan Yuanda Shuyang
9.5.1 Sichuan Yuanda Shuyang Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 CNBG
9.6.1 CNBG Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Biotest
9.7.1 Biotest Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Octapharma
9.8.1 Octapharma Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 CBPO
9.9.1 CBPO Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Hualan Bio
9.10.1 Hualan Bio Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Baxter
9.11.1 Baxter Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 LFB Group
9.12.1 LFB Group Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Shanghai RAAS
9.13.1 Shanghai RAAS Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 83 Figures and 141 Tables)
Figure IVIg Liquid Immune Globulins market, 2015 - 2026 (USD Million)
Figure IVIg Powder Immune Globulins market, 2015 - 2026 (USD Million)
Figure Immunodeficiency market, 2015 - 2026 (USD Million)
Figure Autoimmune Disease market, 2015 - 2026 (USD Million)
Figure Acute Infection market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Immune Globulins market, by country, 2015 - 2026 (USD Million)
-
Table North America Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table North America Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table North America Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Canada Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Canada Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Europe Immune Globulins market, by country, 2015 - 2026 (USD Million)
-
Table Europe Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Europe Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Europe Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Germany Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Germany Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table France Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table France Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Italy Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Italy Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Spain Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Spain Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Globulins market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table China Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table China Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Japan Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Japan Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table India Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table India Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Immune Globulins market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table MEA Immune Globulins market, by country, 2015 - 2026 (USD Million)
-
Table MEA Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table MEA Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table MEA Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Immune Globulins market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Immune Globulins market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Immune Globulins market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table CSL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BPL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kedrion Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Grifols Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sichuan Yuanda Shuyang Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CNBG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biotest Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Octapharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CBPO Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Baxter Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table LFB Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai RAAS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
